Pharma C Investments - Pharma C Invests in Product Earth Expo
Announcement provided by
Pharma C Investments Plc · PCIL08/11/2021 07:00

08 November 2021
Pharma C Investments Plc
("Pharma C" or the "Company")
Pharma C Invests in Product Earth Expo
Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder in the medical cannabis industry with a particular focus on ancillary businesses, is pleased to announce that it has completed its first investment in a company called Product Earth Expo
Product Earth is the
Highlights
· Pharma C is investing
· Product Earth held its first event in 2015 and despite the ban on public events in 2020, hosted a successful, profitable event in August 2021 at the National Agricultural Exhibition Centre
· In response to the pandemic, Product Earth built a digital marketing agency for hemp and cannabis-related businesses
· Product Earth is led by entrepreneurs with deep expertise in cannabis, media, and technology
· Product Earth has the ability and scope to expand its events and services into
Product Earth supported the
Find out more at www.productearthexpo.com/
Sharon Segal, Chair of Pharma C Investments, said: "This is a major first step for Pharma C. The Board has considered a number of investment opportunities since admission to AQSE in May and we are delighted to welcome Product Earth as our first investee company. This investment exemplifies our focus on the non-plant touching, ancillary sector which support the growth of the medical cannabis industry.
"Product Earth has a special place in the
Tom Toumazis, MBE, Chair of Product Earth, said: "Product Earth is entering an exciting chapter as we service a rapidly growing sector in the
"I am looking forward to working with Pharma C and utilising the expertise provided by the Board and management team. At Product Earth, we are committed to providing a world-class event for our customers and their clients, as well as expanding our digital marketing service to offer a range of products for a growing audience. Product Earth is also looking at taking its event to more countries around the world, enabling customers, businesses, patients and experts to connect on a global scale."
Related Party Transaction
Gavin Sathianathan, Investment Strategy Director of Pharma C, is a director and shareholder of Product Earth and the investment is therefore a related party transaction in accordance with Rule 4.6 of the AQSE Growth Market Access Rulebook.
Company update
As at 31 October 2021, Pharma C had cash balances of £607,870.
The Directors of Pharma C Investments plc take responsibility for this announcement.
This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).
- Ends -
Pharma C Investments |
Tel: +44 207 138 3204 |
|
|
Sharon Segal, Chair |
sharon@pharmacinvestments.com |
|
|
|
Novum Securities (AQSE Corporate Adviser) |
Tel: +44 207 399 9429 |
|
|
David Coffman / Lucy Bowden |
|
|
|
|
Blytheweigh (Financial PR/IR- |
Tel: +44 207 138 3204 |
|
|
Tim Blythe |
|
|
Megan Ray |
|
|
|
|
|
|
|
About Pharma C Investments
Pharma C Investments is an investment vehicle targeting the legal medicinal cannabis industry globally. The Company is seeking to identify breakout companies within the legal markets with a particular focus on the
About Product Earth
Product Earth is the
The Company is driven by a team of industry leaders including Tom Toumazis, MBE, Chairman, and Matthew Clifton, Chief Executive Officer. Tom is a renowned portfolio director, investor and adviser, focused on technology, media and the arts, with experience at companies such as ITV, Eurosport and Disney. Matthew Clifton was an early employee of Facebook, working with the Company as Head of Business Product Marketing for EMEA before transitioning into the cannabis sector. Matthew was one of the first six
Due to the impact of Covid-19 related lockdowns, the event industry came to a halt in 2020. In response, Product Earth pivoted business strategy and utilised its Board's expertise in the technology space to provide a digital marketing service for wellness and cannabis-related businesses. This business proved to be an invaluable tool for Product Earth's customers, allowing them to connect with audiences and showcase their innovative and exciting products and services, using the data gathered over the last five years.
Product Earth has the unique opportunity to capitalise on its first mover advantage in the
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.